[go: up one dir, main page]

BR9703886A - Piridinas bicíclicas fusionadas - Google Patents

Piridinas bicíclicas fusionadas

Info

Publication number
BR9703886A
BR9703886A BR9703886A BR9703886A BR9703886A BR 9703886 A BR9703886 A BR 9703886A BR 9703886 A BR9703886 A BR 9703886A BR 9703886 A BR9703886 A BR 9703886A BR 9703886 A BR9703886 A BR 9703886A
Authority
BR
Brazil
Prior art keywords
fused bicyclic
pyridines
bicyclic pyridines
fused
bicyclic
Prior art date
Application number
BR9703886A
Other languages
English (en)
Inventor
Michael Loegers
Gunter Schmidt
Rolf Angerbauer
Carsten Schmeck
Klaus-Dieter Bremm
Hilmar Bischoff
Delf Schmidt
Arndt Brandes
Joachim Schuhmacher
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9703886A publication Critical patent/BR9703886A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR9703886A 1996-07-08 1997-07-08 Piridinas bicíclicas fusionadas BR9703886A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19627430A DE19627430A1 (de) 1996-07-08 1996-07-08 Bicyclisch kondensierte Pyridine

Publications (1)

Publication Number Publication Date
BR9703886A true BR9703886A (pt) 1998-11-03

Family

ID=7799218

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9703886A BR9703886A (pt) 1996-07-08 1997-07-08 Piridinas bicíclicas fusionadas

Country Status (30)

Country Link
US (1) US6063788A (pt)
EP (1) EP0825185A1 (pt)
JP (1) JPH1067751A (pt)
KR (1) KR980009247A (pt)
CN (1) CN1172803A (pt)
AR (1) AR007716A1 (pt)
AU (1) AU722365B2 (pt)
BG (1) BG61972B1 (pt)
BR (1) BR9703886A (pt)
CA (1) CA2209609A1 (pt)
CO (1) CO4870759A1 (pt)
CZ (1) CZ214797A3 (pt)
DE (1) DE19627430A1 (pt)
EE (1) EE9700151A (pt)
HN (1) HN1997000082A (pt)
HR (1) HRP970331A2 (pt)
HU (1) HUP9701158A1 (pt)
ID (1) ID17659A (pt)
IL (1) IL121235A0 (pt)
MA (1) MA24261A1 (pt)
NO (1) NO308738B1 (pt)
NZ (1) NZ328260A (pt)
PE (1) PE87798A1 (pt)
PL (1) PL320954A1 (pt)
SG (1) SG46782A1 (pt)
SK (1) SK92697A3 (pt)
TN (1) TNSN97116A1 (pt)
TR (1) TR199700583A2 (pt)
YU (1) YU28897A (pt)
ZA (1) ZA976021B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
KR20010099937A (ko) 1998-12-23 2001-11-09 윌리암스 로저 에이 심혈관 징후용 콜레스테릴 에스테르 전달 단백질 억제제및 피브르산 유도체의 조합물
US6462091B1 (en) 1998-12-23 2002-10-08 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications
EP1340510A1 (en) 1998-12-23 2003-09-03 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
DE69908643T2 (de) 1998-12-23 2004-05-13 G.D. Searle Llc, Chicago Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen
ATE228012T1 (de) 1998-12-23 2002-12-15 Searle Llc Kombinationen von ileumgallensäuretransports inhibitoren und gallensäure sequestriermitteln für kardiovaskuläre indikationen
EA005815B1 (ru) 1998-12-23 2005-06-30 Джи.Ди.Сирл Ллс Комбинация ингибиторов транспорта желчных кислот в подвздошной кишке и ингибиторов белка, переносящего эфиры холестерина, для сердечно-сосудистых показаний
KR20010102964A (ko) 1998-12-23 2001-11-17 윌리암스 로저 에이 심장혈관 징후를 위한 회장 담즙산 수송 억제인자 및피브린산 유도체의 조합물
US6677341B2 (en) 1999-09-23 2004-01-13 Pharmacia Corporation (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6924313B1 (en) 1999-09-23 2005-08-02 Pfizer Inc. Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6586434B2 (en) 2000-03-10 2003-07-01 G.D. Searle, Llc Method for the preparation of tetrahydrobenzothiepines
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
US6958328B2 (en) * 2001-04-18 2005-10-25 Ortho-Mcneil Pharmaceutical, Inc Arylindenopyridines and related therapeutic and prophylactic methods
US20050239782A1 (en) * 2001-04-18 2005-10-27 Heintzelman Geoffrey R Arylindenopyridines and related therapeutic and prophylactic methods
US6903109B2 (en) 2001-04-18 2005-06-07 Ortho-Muniel Pharmaceutical, Inc. Arylindenopyridines and related therapeutic and prophylactic methods
CA2450957A1 (en) 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions of dispersions of drugs and neutral polymers
WO2003000238A1 (en) 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drug
EP1448546A4 (en) 2001-11-02 2005-02-02 Searle Llc MONO- AND DI-FLUORINATED BENZOTHIEPINE COMPOUNDS AS INHIBITORS OF TRANSPORT OF ACIDICALLY DEPENDENT SODIUM ACILIC (ASBT) BILIARY ACIDS AND TAUROCHOLATE RECOVERY
JP2005521653A (ja) 2002-01-17 2005-07-21 ファルマシア コーポレイション 先端ナトリウム同時依存性胆汁酸輸送(asbt)およびタウロコール酸塩取込みの阻害剤としての新規アルキル/アリールヒドロキシまたはケトチエピン化合物
BR0307344A (pt) 2002-02-01 2004-12-14 Pfizer Prod Inc Composições farmacêuticas de dispersões amorfas de fármacos e materiais formadores de microfase lipofìlica
US20040127510A1 (en) * 2002-04-16 2004-07-01 Heintzelman Geoffrey R. Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
BRPI0413277A (pt) * 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
CN1886124A (zh) 2003-09-26 2006-12-27 日本烟草产业株式会社 抑制残余脂蛋白产生的方法
US7749992B2 (en) 2003-10-08 2010-07-06 Eli Lilly And Company Compounds and methods for treating dislipidemia
ATE402180T1 (de) 2004-03-26 2008-08-15 Lilly Co Eli Verbindungen zur behandlung von dyslipidemie
EP1828137B1 (de) * 2004-12-18 2012-04-25 Bayer Pharma Aktiengesellschaft 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
WO2006082518A1 (en) 2005-02-03 2006-08-10 Pfizer Products Inc. Pharmaceutical compositions with enhanced performance
WO2007048027A2 (en) 2005-10-21 2007-04-26 Novartis Ag Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
DE102006012548A1 (de) * 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
PA8801401A1 (es) * 2007-10-25 2009-05-15 Janssen Pharmaceutica Nv Arilindenopirimidinas y su uso como adenosina a2a
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) * 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
GB8626344D0 (en) * 1986-11-04 1986-12-03 Zyma Sa Bicyclic compounds
NO177005C (no) * 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
NZ237097A (en) * 1990-02-26 1993-12-23 Squibb & Sons Inc Pyridine derivatives substituted in the 3-position by a phosphinic moiety.
JPH059179A (ja) * 1990-09-27 1993-01-19 Takeda Chem Ind Ltd 複素環化合物、その製造法及びacat阻害剤

Also Published As

Publication number Publication date
AU722365B2 (en) 2000-08-03
EE9700151A (et) 1998-02-16
IL121235A0 (en) 1998-01-04
KR980009247A (ko) 1998-04-30
CN1172803A (zh) 1998-02-11
CZ214797A3 (cs) 1998-01-14
NO973144D0 (no) 1997-07-07
TNSN97116A1 (fr) 2005-03-15
BG101746A (en) 1998-03-31
DE19627430A1 (de) 1998-01-15
SG46782A1 (en) 1998-02-20
ID17659A (id) 1998-01-15
HUP9701158A1 (hu) 1999-09-28
MA24261A1 (fr) 1998-04-01
PE87798A1 (es) 1999-02-13
AU2844897A (en) 1998-01-15
NZ328260A (en) 1998-09-24
SK92697A3 (en) 1998-02-04
HU9701158D0 (en) 1997-09-29
TR199700583A2 (xx) 1998-01-21
EP0825185A1 (de) 1998-02-25
NO973144L (no) 1998-01-09
PL320954A1 (en) 1998-01-19
NO308738B1 (no) 2000-10-23
YU28897A (sh) 2000-03-21
BG61972B1 (bg) 1998-11-30
US6063788A (en) 2000-05-16
HN1997000082A (es) 1997-12-26
CO4870759A1 (es) 1999-12-27
CA2209609A1 (en) 1998-01-08
JPH1067751A (ja) 1998-03-10
HRP970331A2 (en) 1998-08-31
AR007716A1 (es) 1999-11-10
ZA976021B (en) 1998-02-02

Similar Documents

Publication Publication Date Title
BR9703886A (pt) Piridinas bicíclicas fusionadas
IS5041A (is) Sambræddar bísýklískar pýrimidín afleiður
BR9703890A (pt) Piridinas heterocíclicas fundidas
DK0738150T3 (da) Bicykliske fibrinogene antagonister
FI971479L (fi) Fuusioituja pyrrolokarbatsoleja
ID23889A (id) Turunan-turunan piridina
NO985222D0 (no) Karbolinderivater
DE69725725D1 (de) Arsenfreie gläser
NO991903D0 (no) Naftyridinderivater
FI943208A0 (fi) Bisyklisiä tetrahydropyratsolopyridiinejä
FI954991L (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
ID19420A (id) Polipeptida fusi
BR9704567A (pt) Elementos de sistemas de fusão
DE69709872D1 (de) Elektroschweisskupplungsvorrichtung
DE69724941D1 (de) Aminopyridin-derivate
DE69700101D1 (de) Drucktasteneinrichtung
DK0862197T3 (da) Sikringsstik
DE69711853D1 (de) Pyridincarboxamid-derivate
KR970052678U (ko) 피리리드
KR960033532U (ko) 기확인기
ZA989529B (en) Bicyclic pyridines
KR980004582U (ko) 안경
KR970006832U (ko) 식별이 용이한 안경
DE69828085D1 (de) Schweissmittel
ZA9710640B (en) Fused bicyclic pyrimidine derivatives

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B11T Dismissal of application maintained [chapter 11.20 patent gazette]